Security
SpyGlass Pharma, Inc. Common Stock · SGP
SGPNASDAQCommon stockCurrentCIK 1778922Updated Oct 6, 2026
Name history
SpyGlassPharma, Inc. · through Jun 5, 2025SpyGlass Ophthalmics, Inc. · through Jan 5, 2021
SGP price & chart
Loading TradingView…
NASDAQ:SGP on TradingView ↗In the news
SpyGlass Pharma Appoints Shannon Treviño as General Counsel ↗
Recent filings
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 1 more recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| AssetsUSD | 243,433,000Source | — | 258,386,000Source | — | 115,866,000Source | 23,318,000Source |
| Property, Plant and Equipment, NetUSD | 4,785,000Source | — | 2,745,000Source | — | 2,339,000Source | 2,168,000Source |
| Current assets: | ||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 223,143,000Source | — | 238,902,000Source | — | 96,358,000Source | 16,268,000Source |
| Assets, CurrentUSD | 236,461,000Source | — | 253,362,000Source | — | 108,768,000Source | 17,406,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,597,000Source | — | 1,707,000Source | — | 901,000Source | 715,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,428,000Source | — | 1,490,000Source | — | 1,552,000Source | 3,291,000Source |
| Other Assets, NoncurrentUSD | 759,000Source | — | 789,000Source | — | 492,000Source | 453,000Source |
| LIABILITIES AND EQUITY | ||||||
| LiabilitiesUSD | 11,069,000Source | — | 8,274,000Source | — | 10,166,000Source | 11,246,000Source |
| Stockholders’ equity: | ||||||
| Common Stock, Value, IssuedUSD | 0Source | — | 0Source | — | 0Source | 0Source |
| Additional Paid in CapitalUSD | 370,776,000Source | — | 368,660,000Source | — | 5,893,000Source | 4,387,000Source |
| Retained Earnings (Accumulated Deficit)USD | -138,412,000Source | — | -118,548,000Source | — | -104,730,000Source | -64,861,000Source |
| Stockholders' Equity Attributable to ParentUSD | 232,364,000Source | -78,379,000Source | 250,112,000Source | -68,852,000Source | -98,837,000Source | -60,474,000Source |
| Liabilities and EquityUSD | 243,433,000Source | — | 258,386,000Source | — | 115,866,000Source | 23,318,000Source |
| Current liabilities: | ||||||
| Liabilities, CurrentUSD | 9,437,000Source | — | 6,667,000Source | — | 8,584,000Source | 7,791,000Source |
| Operating Lease, Liability, CurrentUSD | 0Source | — | 0Source | — | 0Source | 442,000Source |
| Accounts Payable, CurrentUSD | 4,155,000Source | — | 3,514,000Source | — | 2,696,000Source | 1,978,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,632,000Source | — | 1,607,000Source | — | 1,582,000Source | 3,455,000Source |
| Preferred Stock, Value, Issued | —Source | — | —Source | — | — | — |
cash flow · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 1,675,000Source | 345,000Source | 2,786,000Source | 1,490,000Source |
| Changes in operating assets and liabilities: | ||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | 953,000Source | -372,000Source | 549,000Source | 1,339,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | -9,910,000Source | -6,530,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | -13,544,000Source | -8,201,000Source | -32,701,000Source | -22,027,000Source |
| Cash flows from investing activities: | ||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | -1,667,000Source | -164,000Source | -11,794,000Source | 22,261,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | 676,000Source | 164,000Source | 789,000Source | 1,991,000Source |
| Cash flows from financing activities: | ||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | 1,450,000Source | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | 157,755,000Source | 50,096,000Source | 124,585,000Source | 185,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | 142,544,000Source | 41,731,000Source | 80,090,000Source | 419,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 223,143,000Source | 127,235,000Source | 238,902,000Source | 57,999,000Source | 96,358,000Source | 16,268,000Source |
| Supplemental disclosure of cash flow information: | ||||||
| Income Taxes Paid, NetUSD | — | — | 0Source | 4,000Source | 1,000Source | 18,000Source |
| Additional Financial Items | ||||||
| Share-based Payment Arrangement, ExpenseUSD | 2,100,000Source | 600,000Source | 1,700,000Source | 300,000Source | 2,800,000Source | 1,500,000Source |
| DepreciationUSD | 341,000Source | 135,000Source | 318,000Source | 124,000Source | 612,000Source | 271,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 0Source | -3,900Source | 0Source | 0Source | -5,400Source | 0Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | — | 518,000Source | 0Source |
| General and Administrative ExpenseUSD | 11,025,000Source | 1,964,000Source | 6,867,000Source | 1,371,000Source | 12,266,000Source | 7,080,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Investment Income, InterestUSD | 2,103,000Source | 622,000Source | 1,591,000Source | 126,000Source | 3,106,000Source | 1,317,000Source |
| Net Income (Loss) Attributable to ParentUSD | -19,864,000Source | -8,675,000Source | -13,818,000Source | -8,823,000Source | -39,869,000Source | -29,164,000Source |
| Nonoperating Income (Expense)USD | 2,103,000Source | 622,000Source | 1,591,000Source | -1,400,000Source | 1,580,000Source | -2,100,000Source |
| Operating ExpensesUSD | 21,967,000Source | 9,297,000Source | 15,409,000Source | 7,423,000Source | 41,449,000Source | 27,064,000Source |
| Proceeds from Issuance of Redeemable Preferred StockUSD | — | — | 0Source | 50,010,000Source | 127,336,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 55,000Source | 100,000Source | 170,000Source | 185,000Source |
income statement · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | -21,967,000Source | -9,297,000Source | -15,409,000Source | -7,423,000Source | -41,449,000Source | -27,064,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -19,864,000Source | -8,675,000Source | -13,818,000Source | -8,823,000Source | -39,869,000Source | -29,164,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -19,864,000Source | -8,675,000Source | -13,818,000Source | -8,823,000Source | -39,869,000Source | -29,164,000Source |
| Earnings Per Share, BasicUSD per share | -0.59Source | -3.81Source | -0.69Source | -3.96Source | -17.98Source | -16.31Source |
| Earnings Per Share, DilutedUSD per share | -0.59Source | -3.81Source | -0.69Source | -3.96Source | -17.98Source | -16.31Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 33,439,543Source | 2,277,521Source | 19,927,848Source | 2,229,637Source | 2,217,104Source | 1,788,211Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 33,439,543Source | 2,277,521Source | 19,927,848Source | 2,229,637Source | 2,217,104Source | 1,788,211Source |
| Additional Financial Items | ||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | 0Source | 0Source |
| General and Administrative ExpenseUSD | 11,025,000Source | 1,964,000Source | 6,867,000Source | 1,371,000Source | 12,266,000Source | 7,080,000Source |
| Investment Income, InterestUSD | 2,103,000Source | 622,000Source | 1,591,000Source | 126,000Source | 3,106,000Source | 1,317,000Source |
| Nonoperating Income (Expense)USD | 2,103,000Source | 622,000Source | 1,591,000Source | -1,400,000Source | 1,580,000Source | -2,100,000Source |
| Operating ExpensesUSD | 21,967,000Source | 9,297,000Source | 15,409,000Source | 7,423,000Source | 41,449,000Source | 27,064,000Source |
| Research and Development ExpenseUSD | 10,942,000Source | 7,333,000Source | 8,542,000Source | 6,052,000Source | 29,183,000Source | 19,984,000Source |